White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F: EXAMINE Investigators
Phase 2 weight loss (48 weeks): 8.7% at 2 mg maintenance 4 mg Weeks 58 First dose where therapeutic effects become clinically meaningful
Strong antioxidant Free radicals damage the skin cells that cause various skin issues like dark spots, fine lines, and wrinkles
It detects what youve just eaten and tells your body to do the things it needs to do to digest and process those calories. In people with obesity or Type 2 diabetes, this system is often dysregulated, making it harder for the body to manage blood sugar and appetite